NVCN · Neovasc Inc

-

Please sign in to comment on NVCN

1 Comment

Admin

4 years ago

Neovasc Inc is currently in a long term downtrend where the price is trading 25.3% below its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.4.

Neovasc Inc's total revenue sank by 9.2% to $514K since the same quarter in the previous year.

Its net income has increased by 64.2% to $-4M since the same quarter in the previous year.

Finally, its free cash flow fell by 12.7% to $-7M since the same quarter in the previous year.

Based on the above factors, Neovasc Inc gets an overall score of 2/5.

Sector	Healthcare
Industry	Medical Devices
Exchange	NASDAQ
CurrencyCode	USD
ISIN	CA64065J4037

PE Ratio	None
Target Price	24
Dividend Yield	0.0%
Market Cap	84M
Beta	2.01

ABOUT

Neovasc Inc

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.

NVCN · Neovasc Inc

-

Neovasc Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Neovasc Inc using a moving average strategy